The $95 target reflects eight recent, attributed ratings: Citigroup's Tyler Radke (Buy, $149), Piper Sandler's James Fish (Overweight, $124), UBS's Karl Keirstead (Buy, $105), Barclays (Equal-Weight, $105), Goldman Sachs's Gabriela Borges (Buy, $101), Morgan Stanley's Keith Weiss (Equal-Weight, $70), Bernstein's Madison Rezaei (Sell, $54), and HSBC's Abhishek Shukla (Reduce, $39). These average $93.40, which rounds to the $95 central target used here, with a $39-to-$149 range. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The dispersion is unusually wide and tells its own story. Bulls argue the company is a scarce, well-positioned supplier of AI compute with a record backlog; bears focus on leverage, capital intensity, and concentration risk. Independent aggregators citing larger panels of 29 to 41 analysts report somewhat higher averages, near $105 to $115, but this analysis uses only the individually verified, dated targets above rather than any website's headline consensus. Because views diverge so sharply, the average should be read as a midpoint of opinion, not a forecast or guarantee.
With shares near $49.89 and a 52-week range of roughly $40.58 to $138.25, CoreWeave sits far below its highs but above its recent lows. The climb to $95 implies about 90% upside, which is a very large move requiring sustained execution and sentiment repair.
The path depends heavily on fundamentals. In its latest quarter, CoreWeave reported revenue of about $3.66 billion, up 168% year over year, and lifted its full-year 2026 revenue outlook to $13 billion to $13.3 billion. Management has said it expects positive adjusted net income in the first half of 2028. Those figures support the bull case, but the company is simultaneously spending $37 billion to $39 billion on capital expenditures this year, which keeps near-term profitability and cash flow deeply negative.
CoreWeave's 52-week high near $138 and its low near $40.58 frame the long-term range. The $95 target sits well below the prior high, meaning the stock would not need a full round-trip to reach it, but it still faces resistance in the $70-to-$85 zone, where Morgan Stanley and Barclays place cautious targets. The $40 area has acted as a durable support level, and $50 is a psychological level the stock is currently testing. From what I see, monitoring these levels remains essential.
Analyst price targets generally reflect a roughly 12-month research horizon, though firms differ, and none of the targets reviewed here carries a guaranteed timetable. Investors should watch upcoming earnings and guidance, the pricing and completion of new debt facilities, customer-contract renewals, capital-spending discipline, and any changes in interest-rate expectations. Revisions to analyst targets — which have been volatile in both directions this year — are a key signal of shifting sentiment. I’m watching this closely as the situation evolves.
In my view, tools like Tickeron’s AI Daily Buy/Sell Signals can help track momentum shifts in names like this one. The platform applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market conditions. It offers a practical way to stay on top of fast-moving situations without constant manual review.
The $95 central target for CoreWeave, derived from eight verified analyst targets, implies roughly a 90% move from the current price near $49.89 — an ambitious but not unprecedented climb for a high-growth AI-infrastructure stock. The bull case rests on explosive revenue growth, a massive backlog, and improving financing clarity; the bear case rests on heavy capex, leverage, customer concentration, and the absence of near-term profitability. The $39-to-$149 analyst range shows genuine disagreement about the company's risk-reward profile. Whether CoreWeave approaches $95 will likely hinge on execution against its backlog, disciplined capital spending, and the durability of AI-compute demand — factors investors should track closely, with no guarantees in either direction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Stochastic Oscillator for CRWV moved out of overbought territory on November 16, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 23 similar instances where the indicator exited the overbought zone. In 21 of the 23 cases the stock moved lower. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CRWV entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CRWV's RSI Oscillator exited the oversold zone, 6 of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for CRWV just turned positive on November 11, 2026. Looking at past instances where CRWV's MACD turned positive, the stock continued to rise in 15 of 16 cases over the following month. The odds of a continued upward trend are 90%.
Following a +12.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in 83 of 91 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
CRWV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.094) is normal, around the industry mean (16.275). P/E Ratio (-13.070) is within average values for comparable stocks, (45.369). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.430) among similar stocks. P/S Ratio (5.721) is also within normal values, averaging (103.897).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. CRWV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications